Fulcrum Therapeutics
Price & Volume
Stats
See more52W Range | $2.83-$15.73 |
Market Cap | $233.2M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$56.7M |
Diluted EPS | -$1.15 |
News
See moreYahoo Finance • last month
Levi & Korsinsky Announces Investigation of Securities Claims Against Fulcrum Therapeutics, Inc. (FULC)
Yahoo Finance • last month
Fulcrum Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses
Yahoo Finance • last month
This Biotech Stock Plunges 48%. Its Sickle Cell Drug Has ‘No Viable Path Forward.’
About
CEO | Mr. Alexander C. Sapir |
Address | 26 Landsdowne Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 55 |